eCliniqua Briefs – Nov. 3, 2008



Phase Forward Inc. announced its financial results for the third quarter of 2008. Revenues for the third quarter were $43.0 million, a 23 percent increase from $34.9 million in the third quarter of 2007. Within total revenues, InForm license, application hosting and other related revenues were $32.7 million, representing 76 percent of third quarter total revenues and an increase of 28 percent from $25.5 million in the prior year period.  The company also noted that its customer, GlaxoSmithKline, won a 2008 Technology Innovation Award from The Wall Street Journal, taking top honors in the Healthcare IT category. The Innovation Award recognized GSK’s Molecular Clinical Safety Intelligence (MCSI) system, co-developed with the Phase Forward Lincoln Safety Group. Read more.

OmniComm Systems Inc. announced another good quarter for new business. Signed contracts through the first three quarters of 2008, totaling $15.8 million, are exceeding projected expectations for the year. Thomas Wells, VP of technology for OmniComm, said, “OmniComm’s vision for early 2009 includes the creation of a Centralized Data Hub where eClinical services can be seamlessly integrated with our client’s systems and repositories.  This solution will empower our clients to take control of their data and better leverage core industry standards like CDISC/CDASH and STDM." Read the press release. 

Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, has been awarded a federal Indefinite Delivery Indefinite Quantity (IDIQ) contract with a first task order totaling $1.7 million from the National Institutes of Child Health and Human Development (NICHD) to provide clinical trial management services for a study to be conducted by the Division of Epidemiology, Statistics and Prevention Research (DESPR). Throughout the study, C-TASC will use its StudyCTMS  study management software solution to provide Data Coordinating Center (DCC) services, including a fully operational, state-of-the-art data management system, management of biospecimen and radiology data shipment and inventory, statistical expertise and programming and logistical support.

TAKE Solutions’ Life Sciences division released PharmaReady version 4.1 with powerful new enhancements to the web-based suite of products.  The PharmaReady document management system includes virtual document workflow and interface enhancements, enhanced Office 2007 integration and support, and document owner functionality and role. The system’s electronic submissions capabilities include eCTD enhanced support for Canadian STF Submissions, enhanced Acrobat support, and support for updated eCTD guidance from FDA.

Exco InTouch came in second at the 2008 Good Clinical Practice Journal (GCPj) Awards in the category of Most Innovative Patient Recruitment Strategy. The awards were organized by Informa Healthcare, a provider of business information for the biotechnology and medical devices industries and involved a panel of judges from prominent global pharmaceutical organizations. This recognition follows Exco InTouch's recent success at the European Outsourcing Awards and was received in recognition of the company's text message-based participant communication strategy developed for MDS Pharma Services.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .